GB2297751A - Binding structures directed against the ca55.1 antigen - Google Patents

Binding structures directed against the ca55.1 antigen

Info

Publication number
GB2297751A
GB2297751A GB9607974A GB9607974A GB2297751A GB 2297751 A GB2297751 A GB 2297751A GB 9607974 A GB9607974 A GB 9607974A GB 9607974 A GB9607974 A GB 9607974A GB 2297751 A GB2297751 A GB 2297751A
Authority
GB
United Kingdom
Prior art keywords
seq
antigen
directed against
binding structures
cdr1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9607974A
Other versions
GB2297751B (en
GB9607974D0 (en
GB2297751A8 (en
Inventor
Michael Samuel Rose
Christopher Boot
Clive Graham Copley
Douglas Stephen Paterson
Susan Margaret Hall
Andrew Firmin Wright
David Charles Blakey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939324819A external-priority patent/GB9324819D0/en
Priority claimed from GB9411089A external-priority patent/GB9411089D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GB9607974A priority Critical patent/GB2297751B/en
Priority claimed from PCT/GB1994/002610 external-priority patent/WO1995015382A1/en
Publication of GB9607974D0 publication Critical patent/GB9607974D0/en
Publication of GB2297751A publication Critical patent/GB2297751A/en
Publication of GB2297751A8 publication Critical patent/GB2297751A8/en
Application granted granted Critical
Publication of GB2297751B publication Critical patent/GB2297751B/en
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046Stomach, Intestines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Antibodies which recognise a tumour related antigen designated CA55.1 such as hybridoma 55.1 deposited as ECACC deposit No. 93081901 in which the complementary determining regions have the following sequences: a) heavy chain: CDR1: G Y W I H (SEQ ID NO: 27); CDR2: E V N P S T G R S D Y N E K F K N (SEQ ID NO: 28); CDR3: E R A Y G Y D D A M D Y (SEQ ID NO: 29); b) light chain: CDR1: K S S Q S L L N S R T R K N Y L A (SEQ ID NO: 30); CDR2: W A S T R T S (SEQ ID NO: 31); CDR3: K Q S Y T L R T (SEQ ID NO: 32); or a conservative analogue thereof. The peptide ACEHRGSGWC (SEQ ID NO: 26), as displayed on the surface of bacteriophage NCIMB No. 40638, is a mimic of the tumor related antigen CA55.1.
GB9607974A 1993-12-03 1994-11-29 Binding structures directed against the ca55.1 antigen Revoked GB2297751B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9607974A GB2297751B (en) 1993-12-03 1994-11-29 Binding structures directed against the ca55.1 antigen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939324819A GB9324819D0 (en) 1993-12-03 1993-12-03 Proteins
GB9411089A GB9411089D0 (en) 1994-06-03 1994-06-03 Proteins
GB9607974A GB2297751B (en) 1993-12-03 1994-11-29 Binding structures directed against the ca55.1 antigen
PCT/GB1994/002610 WO1995015382A1 (en) 1993-12-03 1994-11-29 Binding structures directed against the ca55.1 antigen

Publications (4)

Publication Number Publication Date
GB9607974D0 GB9607974D0 (en) 1996-06-19
GB2297751A true GB2297751A (en) 1996-08-14
GB2297751A8 GB2297751A8 (en) 1996-09-23
GB2297751B GB2297751B (en) 1997-11-26

Family

ID=27266962

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9607974A Revoked GB2297751B (en) 1993-12-03 1994-11-29 Binding structures directed against the ca55.1 antigen

Country Status (1)

Country Link
GB (1) GB2297751B (en)

Also Published As

Publication number Publication date
GB2297751B (en) 1997-11-26
GB9607974D0 (en) 1996-06-19
GB2297751A8 (en) 1996-09-23

Similar Documents

Publication Publication Date Title
GB9424108D0 (en) Proteins
NZ614727A (en) Human antibodies that bind human tnfa
NZ593068A (en) IL-18 antibody
NZ547157A (en) Interferon Alpha Antibodies and their uses
RS51373B (en) Antibodies to insulin-like growth factor i receptor
EA200100698A1 (en) HUMAN MONOCLONAL ANTIBODIES TO CTLA-4
NZ331978A (en) Monoclonal antibody to CEA (carcinomembryonic antigen), conjugates comprising said antibody, and their therapeutic use in an adept system
NZ611387A (en) Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment
RS52484B (en) Antibodies to cd40
HK1134303A1 (en) Fab fragment libraries and methods for their use fab
NZ529571A (en) Human antibodies that bind human IL-12 and methods for producing
CA2328851A1 (en) Humanized immunoglobulins and their production and use
IL136544A0 (en) Humanization of murine antibody
AU638535B2 (en) Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")
CA2103059A1 (en) Method for making humanized antibodies
GR3030210T3 (en) Method of selecting specific bacteriophages
WO1998050433A3 (en) Human monoclonal antibodies to epidermal growth factor receptor
SG151284A1 (en) Antibodies against ccr5 and uses thereof
WO1996020277A3 (en) Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
GR3017734T3 (en) Humanised antibodies.
AU628948B2 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
WO1999003987A3 (en) Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
IL114179A0 (en) Interleukin-5 specific recombinant antibodies
HRP20030805B1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
CA2105979A1 (en) Monoclonal antibody against lps core

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
773K Patent revoked under sect. 73(2)/1977

Free format text: PATENT REVOKED ON 20050523